**8. References**


consequent signalling amplification systems, such as the tyrosine kinase p56lck, phosphatase CD45 and downstream ERK1/2 (Dennert et al., 2008). Preventing direct viral damage using antiviral therapy is another possible approach by use of specific viral drugs (anti-protease or inhibitors of RNA/DNA polymerases) or by use of general antiviral strategies (interfering RNA). Future randomized placebo-controlled trials should be based upon aetiological diagnosis (viral vs. other causes) and may provide novel treatment

Andréoletti, L., Wattre, P., Decoene, C., Lobert, PE., Dewilde, A., & Hober, D. (1995).

Andréoletti, L., Hober, D., Becquart, P., Belaich, S., Copin, MC., Lambert, V., & Wattré, P.

Andréoletti, L., Bourlet, T., Moukassa, D., Rey, L., Hot, D., Li, Y., Lambert, V., Gosselin, B.,

Andréoletti, L., Ventéo, L., Douche-Aourik, F., Canas, F., Lorin de la Grandmaison, G.,

suddenly of acute myocardial infarction. J Am Coll Cardiol. 50:2207-2214. Andréoletti, L., Lévêque, N., Boulagnon, C., Brasselet, C., & Fornes, P. (2009). *Viral causes of* 

Aretz, HT., Billingham, ME., Edwards, WD., Factor, SM., Fallon, JT., Fenoglio, JJ., Olsen,

Ayach, B., Fuse, K., Martino, T., & Liu, P. (2003). Dissecting mechanisms of innate and

Badorff, C., Lee, GH., Lamphear, BJ., Martone, ME., Campbell, KP., Rhoads, RE., Knowlton,

Badorff, C., Zeiher, AM., Hohnloser, SH. (2001). *Torsade de pointes tachycardia as a rare* 

Baughman, KL. (2006). Diagnosis of myocarditis: death of Dallas criteria. Circulation 113 :

Bock, CT., Klingel, K., & Kandolf, R. (2010). *Human parvovirus B19-associated myocarditis*. N

Bönsch, C., Zuercher, C., Lieby, P., Kempf, C., Ros, C. (2010). The globoside receptor triggers

structural changes in the B19 virus capsid that facilitate virus internalization. J

acquired immunity in myocarditis Curr Opin Cardiol. 18 : 175-181.

disruption in an acquired cardiomyopathy. Nat Med. 5:320-326.

*manifestation of acute enteroviral myocarditis*. Heart 86:489-490.

Detection of enterovirus-specific RNA sequences in explanted myocardium biopsy specimens from patients with dilated or ischemic cardiomyopathy. Clin Infect Dis

(1997). Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in

Mosnier, JF., Stankowiak, C., & Wattré, P. (2000). Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic

Jacques, J., Moret, H., Jovenin, N., Mosnier, JF., Matta, M., Duband, S., Pluot, M., Pozzetto, B., & Bourlet, T. (2007). Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died

EG., & Schoen, FJ. (1987). Myocarditis. With histopathologic definition and

KU. (1999). Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal

options and possibly a better prognosis for these selected patients.

persistent cardiac infection. J Med Virol 52:206-214.

or dilated cardiomyopathy. J Infect Dis 182:1222-1227.

*human myocarditis*. Arch Cardiovasc Dis. 102:559-68.

classification. Am J Cardiovasc Pathol 1:3-14.

**8. References** 

21:1315-1317.

593-595.

Engl J Med. 362:1248-9.

Virol. 84:11737-46.


Viral Myocarditis: Physiopathology and Diagnosis 103

Liu, PP., & Mason, JW. (2001). Advances in the understanding of myocarditis. Circulation.

Mahfoud, F., Gärtner, B., Kindermann, M., Ukena, C., Gadomski, K., Klingel, K., Kandolf, R.,

Magnani, JW., & Dec, GW. (2006). Myocarditis: current trends in diagnosis and treatment.

Mahrholdt, H., Goedecke, C., Wagner, A., Meinhardt, G., Athanasiadis, A., Vogelsberg, H.,

Matsumori, A., & Kawai, C. (1982). *An animal model of congestive (dilated) cardiomyopathy:* 

Matsumori, A., Yamada, T., Suzuki, H., Matoba, Y., & Sasayama, S. (1994). Increased

Oldstone, MB. (2006). *Viral persistence: parameters, mechanisms and future predictions.* Virology.

Renois, F., Talmud, D., Huguenin, A., Moutte, L., Strady, C., Cousson, J., Lévêque, N., &

Santoro, F., Kennedy, PE., Locatelli, G., Malnati, MS., Berger, EA., & Lusso, P. (1999). *CD46* 

Schönian, U., Crombach, M., Maser, S., & Maisch, B. (1995). Cytomegalovirus-associated

Seko, Y., Tsuchimochi, H., Nakamura, T., Okumura, K., Naito, S., Imataka, K., Fujii, J.,

Shi, Y., Chen, C., Lisewski, U., Wrackmeyer, U., Radke, M., Westermann, D., Sauter, M.,

Takano, H., Nakagawa, K., Ishio, N., Daimon, M., Kobayashi, Y., Hiroshima, K., & Komuro,

Sudano, I., Spieker, LE., Noll, G., Corti, R., Weber, R., & Luscher, TF. (2006). Cardiovascular

Ventéo, L., Bourlet, T., Renois, F., Douche-Aourik, F., Mosnier, JF., Maison, GL., Pluot, M.,

*myocarditis caused by encephalomyocarditis virus.* Circulation 66:355-360. Matsumori, A., Shimada, T., Chapman, NM., Tracy, SM., & Mason, JW. (2006). Myocarditis

*myocarditis: utility or futility?* Eur Heart J. 32:897-903.

molecular pathology. Circulation. 109:1250-8.

*DNA microarray systems.* J Clin Microbiol. 48:3836-42.

heart muscle disease. Eur Heart J. Suppl O:46-9.

infection. Int J Cardiol. 130:e11– e13.

myocarditis. Eur Heart J. 31:728-36.

*is a cellular receptor for human herpesvirus 6.* Cell. 99:817-27.

prevents myocarditis in vivo. J Am Coll Cardiol. 53:1219-26.

disease in HIV infection. Am Heart J. 151:1147-1155.

Böhm, M., & Kindermann, I. (2011). *Virus serology in patients with suspected* 

Fritz, P., Klingel, K., Kandolf, R., & Sechtem, U. (2004). Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and

*dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with* 

and heart failure associated with hepatitis C virus infection. J Card Fail. 12:293-298.

circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J.

Andréoletti, L. (2010). *Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR* 

Takaku, F., Yazaki, Y. (1990). Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with Coxsackievirus B3. Circ Res

Tschöpe, C., Poller, W., Klingel, K., & Gotthardt, M. (2009). Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and

I. (2008). Active myocarditis in a patient with chronic active Epstein-Barr virus

Pozzetto, B., & Andreoletti, L. (2010). Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute

104 : 1076-1082.

72 : 561-566.

344:111-8.

67:360-367.

Circulation 113:876-890.


Feire, AL., Koss, H., & Compton, T. (2004). Cellular integrins function as entry receptors for

Gravanis, MB., & Sternby, NH. (1991). Incidence of myocarditis. A 10-year autopsy study

Grodums, EI., & Zbitnew, A. (1976). *Experimental herpes simplex virus carditis in mice.* Infect

Huber, SA. (1993). Animal models: immunological aspects. In Banatvla JE, ed, Viral

Kawai, C. (1999). From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 99 : 1091-1100. Kramer, M., Schulte, BM., Toonen, LW., de Bruijni, MA., Galama, JM., Adema, GJ., van

Kramer, M., Schulte, BM., Toonen, LW., Barral, PM., Fisher, PB., Lanke, KH., Galama, JM.,

Kühl U., Pauschinger M., Schwimmbeck P.L., Seeberg, B., Lober, C., Noutsias, M., Poller, W.,

viral genomes and left ventricular dysfunction. Circulation. 107 : 2793-2798. Kühl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, T., Lassner, D., Poller, W.,

Kühl, U., Pauschinger, M., Seeberg, B., Lassner, D., Noutsias, M., Poller, W., & Schultheiss,

Kyto, V., Vuorinen, T., Saukko, P., Lautenschlager, I., Lignitz, E., Saraste, A., & Voipio-

Lee, GH., Badorff, C., & Knowlton, KU. (2000). Dissociation of sarcoglycans and the

Lenzo, JC., Fairweather, D., Cull, V., Shellam, GR., & James Lawson, CM. (2002).

Li, Y., Bourlet, T., Andréoletti, L., Mosnier, JF., Peng, T., Yang, Y., Archard, LC., Pozzetto, B.,

Kuppeveld, FJ. (2007). *Echovirus infection causes rapid loss-of-function and cell death in* 

van Kuppeveld, FJ., & Adema, GJ. (2008). *Phagocytosis of picornavirus-infected cells induces an RNA-dependent antiviral state in human dendritic cells*. J Virol. 82:2930-7. Kühl, U., Noutsias, M., Seeberg, B., & Schultheiss, HP. (1996). *Immunohistological evidence for* 

*a chronic intramyocardial inflammatory process in dilated cardiomyopathy.* Heart 75:295-

& Schultheiss, HP. (2003). Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of

Kandolf, R., & Schultheiss HP. (2005a). High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left

HP. (2005b). *Viral persistence in the myocardium is associated with progressive cardiac* 

Pulkki, LM. (2005). Cytomegalovirus infection of the heart is common in patients

dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.

*Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart* 

& Zhang, H. (2000). Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation

Feldman, AM., & McNamara, D. (2000). Myocarditis. N Engl J Med 343:1388-1398.

from Malmo, Sweden. Arch Pathol Lab Med. 115:390-392.

Infections in the Heart. London, Edward Arnold, 82-109.

*human dendritic cells.* Cell Microbiol. 9:1507-18.

ventricular dysfunction. Circulation. 111:887-893.

with fatal myocarditis. Clin Infect Dis. 40:683– 688.

*and virus persistence*. J Mol Cell Cardiol. 34:629-40.

*dysfunction.* Circulation 112:1965-1970.

Circ Res 87:489–495.

101:231-234.

Acad Sci U S A. 101:15470-5.

Immun. 14:1322-31.

300.

human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl


**5** 

*1,3USA 2,4Egypt* 

**Perimyocarditis** 

Yara Mikhaeil3 and Ahmed Fathy4

Hesham R. Omar1, Hany Abdelmalak1, Engy Helal2,

*2Emergency Department, Agouza Police Hospital, Cairo, Egypt* 

*4Cardiology Department. National Heart institute. Cairo, Egypt* 

*3Northwestern University, Feinberg School of Medicine.* 

*1Internal Medicine Department. Mercy Hospital and Medical Center, Chicago, Illinois,* 

Perimyocarditis is an acute inflammation of the pericardium and the underlying myocardium resulting in myocellular damage. It can simply be considered as acute pericarditis with elevated cardiac biomarkers. The coexistence of acute myocarditis and pericarditis is not uncommon since both are commonly caused by cardiotropic viruses. The 2 terms "perimyocarditis" and "myopericarditis" are used to describe the disease. While perimyocarditis implies predominant myocardial involvement and myopericarditis implies predominant pericardial involvement, both terms are used interchangeably without specific reference to the type of cardiac involvement. There is a wide spectrum of clinical presentations reflecting the extent of myocardial involvement ranging from asymptomatic cases with spontaneous recovery, to mild cases where symptoms are masked by the existing illness, to more severe cases complicated with heart failure necessitating inotropic support or even cardiac transplantation. Due to detrimental complications of acute myocarditis including left ventricular dysfunction and ventricular arrhythmias the diagnosis of myocarditis is more important and should be thoroughly looked for. Monitoring of the cardiac biomarkers is therefore mandatory in every patient presenting with clinical picture and electrocardiographic (EKG) evidence of acute pericarditis to exclude an underlying myocarditis. Acute pericarditis can present with ST segment elevation which can sometimes be focal rather than diffuse. In this scenario, chest pain associated with focal ST segment elevation and elevated cardiac biomarkers (if myocarditis co-existed) can mimic transmural myocardial infarction. Differentiation between both entities is of utmost importance to avert the un-necessary utilization of thrombolytic therapy which can be deleterious in perimyocarditis or to avoid missing a more serious diagnosis of ST segment elevation myocardial infarction (STEMI). After hospital discharge, patients should be followed for several weeks to exclude the

development of heart failure or subclinical left ventricular dysfunction.

Similar to myocarditis, perimyocarditis is most commonly of viral aetiology and less likely due to bacterial infection. Viral etiologies are predominately due to the coxsackie B virus,

**1. Introduction** 

**2. Etiology** 

